Galectin Therapeutics Inc. (GALT)
NASDAQ: GALT · Real-Time Price · USD
3.760
+0.030 (0.80%)
Oct 6, 2026, 4:00 PM EDT - Market closed
Galectin Therapeutics Employees
Galectin Therapeutics had 9 employees as of December 31, 2025. The number of employees decreased by 6 or -40.00% compared to the previous year.
Employees
9
Change (1Y)
-6
Growth (1Y)
-40.00%
Revenue / Employee
n/a
Profits / Employee
-$3,114,111
Market Cap
379.19M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 9 | -6 | -40.00% |
| Dec 31, 2024 | 15 | 1 | 7.14% |
| Dec 31, 2023 | 14 | 2 | 16.67% |
| Dec 31, 2022 | 12 | 3 | 33.33% |
| Dec 31, 2021 | 9 | 3 | 50.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| ARS Pharmaceuticals | 200 |
| Kyverna Therapeutics | 149 |
| Enanta Pharmaceuticals | 120 |
| Editas Medicine | 87 |
| Prelude Therapeutics | 79 |
| Zura Bio | 40 |
| Opus Genetics | 28 |
| vTv Therapeutics | 26 |
GALT News
- 22 hours ago - Galectin Therapeutics to Present at the American Association for the Study of Liver Diseases (AASLD) Liver Meeting 2026 - GlobeNewsWire
- 4 days ago - Galectin Therapeutics Proxy statement: Proxy filing - Filings
- 22 days ago - Galectin Therapeutics Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 26 days ago - Galectin Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewsWire
- 5 weeks ago - 20 stocks likely to lose money even if the bull market continues - Market Watch
- 7 weeks ago - Galectin Therapeutics Reports June 30, 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 7 weeks ago - Galectin Therapeutics Quarterly report: Q2 2026 - Filings
- 7 weeks ago - Galectin Therapeutics Earnings release: Q2 2026 - Filings